Trials / Unknown
UnknownNCT03069339
Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis
Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 330 (actual)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Study Design: Open labeled randomized controlled trial. The study will be conducted on patients attending outpatient or admitted to admitted to Department of Hepatology from January 2017 to December 2018 at ILBS, New Delhi
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carvedilol | Carvedilol will start at starting dose of 3.125 mg BD followed by 6.25 mg BD followed by 12.5 mg BD if BP 90/60 mmHg and HR 55/min |
| PROCEDURE | Endoscopic Variceal Ligation | EVL will be done every 3 weeks till eradication |
Timeline
- Start date
- 2017-03-15
- Primary completion
- 2020-11-30
- Completion
- 2020-11-30
- First posted
- 2017-03-03
- Last updated
- 2020-02-19
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03069339. Inclusion in this directory is not an endorsement.